| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
4 companies
Domain Partners VIII, L.P. last filed a Form 4 in August 2018, as 10% Owner at ATYR. The filings on record cover 4 companies.
At the last filing, the largest reported position was 876,083 shares of GKOS.
Domain Partners VIII, L.P. has 4 Form 4 filings on record from May 2015 to August 2018, across 4 companies: 10% Owner at Bionano Genomics (BNGO), 2018; 10% Owner at Syndax Pharmaceuticals (SNDX), 2016; 10% Owner at Glaukos (GKOS), 2015, and 1 more.
The 7 reported transactions were 5 conversions and 2 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $92K and no sales.
The only open-market purchase was 15,000 shares of BNGO at an average $6.13 on August 23, 2018, about $92K.
Shares as reported in the last Form 4 for each company; the most recent is from August 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2018 | BNGO Bionano Genomics, Inc. | 10% Owner | Buy | 15,000 | $6.13 | $91,875.00 | +1.6% |